Coronavirus Entry Inhibitors.
Adv Exp Med Biol
; 1366: 101-121, 2022.
Article
Dans Anglais
| MEDLINE | ID: covidwho-1782743
ABSTRACT
Coronaviruses (CoVs) are enveloped RNA viruses that widely exist in the environment. Several CoVs possess a strong ability to infect humans, termed as human coronavirus (HCoVs). Among seven known HCoVs, SARS-CoV-2, SARS-CoV, and MERS-CoV belong to highly pathogenic HCoVs, which can cause severe clinical symptoms and even death. Especially, the current COVID-19 pandemic severely threatens human survival and health, which emphasizes the importance of developing effective CoV vaccines and anti-CoV agents to protect humans from HCoV infections. Coronavirus entry inhibitors can block various processes in viral entry, such as receptor binding, proteolytic activation of spike protein, or virus-cell membrane fusion. Coronavirus entry inhibitors, alone or in combination with other drugs, play important roles in the treatment of coronavirus diseases. Thus, we summarize and discuss the development of coronavirus entry inhibitors in this chapter.
Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Coronavirus du syndrome respiratoire du Moyen-Orient
/
Type d'étude:
Étude pronostique
Les sujets:
Vaccins
Limites du sujet:
Humains
langue:
Anglais
Revue:
Adv Exp Med Biol
Année:
2022
Type de document:
Article
Pays d'affiliation:
978-981-16-8702-0_7
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS